Tralokinumab as a therapeutic option for patients with concurrent atopic dermatitis and alopecia areata

Int J Dermatol. 2024 Mar;63(3):374-375. doi: 10.1111/ijd.17010. Epub 2024 Jan 10.

Authors

Gianluca Tavoletti^#^{1

2}, Alessandra Chiei-Gallo^#², Francesca Barei¹, Angelo V Marzano^{1

2}, Silvia M Ferrucci¹

Affiliations

¹ Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
² Department of Pathophysiology and Transplantation, Università degli Studi Di Milano, Milan, Italy.

^# Contributed equally.

PMID: 38197323
DOI: 10.1111/ijd.17010

No abstract available

Publication types

Letter

MeSH terms

Alopecia Areata* / complications
Alopecia Areata* / drug therapy
Antibodies, Monoclonal / therapeutic use
Dermatitis, Atopic* / complications
Dermatitis, Atopic* / drug therapy
Humans

Substances

tralokinumab
Antibodies, Monoclonal

Supplementary concepts

Diffuse alopecia